Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines

Gemcitabine and paclitaxel are active agents in the treatment of non-small-cell lung cancer (NSCLC). To optimize treatment drug combinations, simultaneously and 4 and 24 h intervals, were studied using DNA flow cytometry and multiple drug effect analysis in the NSCLC cell lines H460, H322 and Lewis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroep, J R, Giaccone, G, Tolis, C, Voorn, D A, Loves, W J P, Groeningen, C J van, Pinedo, H M, Peters, G J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363564/
https://www.ncbi.nlm.nih.gov/pubmed/10993656
http://dx.doi.org/10.1054/bjoc.2000.1399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363564/
https://www.ncbi.nlm.nih.gov/pubmed/10993656
http://dx.doi.org/10.1054/bjoc.2000.1399

Ejemplares similares